As the person who wrote one of the late night posts, I was not posting drunk.
To advise the future director of marketing for Miraca I propose the following. All GI, urology, dermatology, and oncology private practice groups of any size have already, or are in the process, of building their own in-office anatomic and/or clinical laboratories. They are explicitly allowed to do this through the in-office ancillary services (IOAS) loophole in the Stark law.
When Miraca comes to talk them, they say that we bill globally for all our pathology and clinical laboratory testing. We pay some local schmuck pathologist 5$ per case and keep all the rest for ourselves. That means for $100 dollars for an 88305 medicare biopsy, the private practice keeps $95 and gives $5 to the contracted pathologist.
Quality of pathology reads, subspecialty expertise and fellowship training, turn-around-time, and free electronic medical record systems and interfaces (all which Miraca can offer) amount to nothing. Revenue for the practice is everything. The practice managers will say to the Miraca sales rep, if you do our pathology for $4 per case, then you've got a deal! Then LabCorp comes in and says, I'll do it for $3 a case. Race to the bottom. Honestly, how do you sell in this environment?
Unless the IOAS loophole is closed by federal law, this company is cooked.